Elizabeth Hanna
Director/Board Member at TREACE MEDICAL CONCEPTS, INC.
Net worth: 125 397 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jaime A. Frias | M | 62 | 7 years | |
| Scot Elder | M | 49 | 2 years | |
| John Treace | M | 52 | 10 years | |
| Victor Micati | M | 83 |
Origin Life Sciences, Inc.
 Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | 10 years |
| Lance Berry | M | 51 | 2 years | |
| Sean Scanlan | M | 42 | 6 years | |
| Deepti Jain | F | 56 | 3 years | |
| William Hait | M | 74 | 17 years | |
| Lawrence Hamilton | M | 66 | 4 years | |
| Jane Kiernan | F | 63 | 2 years | |
| Peter Fasolo | M | 61 | 18 years | |
| Mark McClellan | M | 60 | 11 years | |
| Tony Brampton | M | 66 |
Origin Life Sciences, Inc.
Origin Life Sciences, Inc. BiotechnologyHealth Technology Origin Life Sciences, Inc. is a clinical-stage biotechnology company, which engages in the development of a plasma device that generate nitric oxide (NO) in the form of a plasma or NO stream. It focuses on its IonoJet platform, which provides therapeutic treatments which helps in immune system and blood vessel regulation, and tissue regeneration. The company was founded by Michael D. Preston and Alexander Dolgopolsky on June 14, 2010 and is headquartered in Princeton, NJ. | 10 years |
| John Bakewell | M | 62 | 4 years | |
| Richard Mott | M | 65 | 9 years | |
| Anne Mulcahy | F | 70 | 15 years | |
| David Schreiber | M | 64 |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
| Mark Hair | M | 54 | 4 years | |
| Shana R. Zink | F | - | - | |
| James Treace | M | 77 | 10 years | |
| Terry Lubben | M | - | - | |
| Daniel E. Owens | M | 52 | 3 years | |
| Aaron Berutti | M | 45 | 3 years | |
| Ronald Andrews | M | 64 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 1 years |
| Rachel Osbeck | F | - | 9 years | |
| Nathan Minnich | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russell C. Deyo | M | 74 | 27 years | |
| John Johnson | M | 66 | 19 years | |
| Joseph Scodari | M | 71 | 9 years | |
| Sherilyn McCoy | F | 65 | 30 years | |
| Matthew Stuckley | M | - | 14 years | |
| Thomas Timbie | M | 65 | 9 years | |
| Evan Norton | M | 49 | 3 years | |
| Rosemary Crane | F | 64 | 6 years | |
| Bastiaan van der Baan | M | 52 |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | 11 years |
| Ian Davis | M | 73 | 13 years | |
| Colleen Goggins | F | 68 | 30 years | |
| Bryan Pinciaro | M | - | 1 years | |
| Curtis Selquist | M | 79 | 36 years | |
| Sarah L. Colamarino | F | - | 13 years | |
| Christopher DelOrefice | M | 52 | 8 years | |
| Joe W. Ferguson | M | 55 | 7 years | |
| Julie Dewey | F | - | - | |
| A. Washington | M | 73 | - | |
| Christophe Soulier | M | - | 5 years | |
| William Weldon | M | 75 | 41 years | |
| Christine Poon | F | 71 | 9 years | |
| Robert J. Darretta | M | 78 | 39 years | |
| F. Bays | M | 77 | 9 years | |
| William Perez | M | 76 | 13 years | |
| Ronald Williams | M | 74 | 11 years | |
| Suneel Gupta | M | 66 | 6 years | |
| Clivetty Martinez | M | - | 14 years | |
| Alicia Sontag | F | - | 4 years | |
| Charles Austin | M | 68 | - | |
| Lynda M. Wallace | F | 61 | 9 years | |
| Mai Jing Liao | M | 54 | 3 years | |
| Sandy Pound | F | - | 14 years | |
| Kim Rodriguez | F | - | 2 years | |
| Natasha Kehimkar | F | - | 2 years | |
| Regev Yativ | M | - | 1 years | |
| Roberto di Bernardini | M | 60 | 9 years | |
| Tom Luby | M | - | 6 years | |
| Sheri Dodd | F | 58 | 13 years | |
| Joseph F. Amaral | M | 68 | 11 years | |
| Jill Pemberton | F | 54 | 6 years | |
| Brian Imszennik | M | - | 6 years | |
| Pericles Stamatiadis | M | - | 28 years | |
| Leah Neufeld | F | 51 | 7 years | |
| Clifton Chang | M | - | 17 years | |
| Yves Decadt | M | 57 | 5 years | |
| Donna Godward | F | 69 | 6 years | |
| Laurent Metz | M | - | 7 years | |
| Karen Prange | F | 60 | 17 years | |
| Valerie Asbury | F | 64 | 5 years | |
| Adam Hacker | M | 55 | 10 years | |
| Minnie Baylor-Henry | F | 76 | 4 years | |
| Robert E. Kirby | M | 67 | 2 years | |
| Angela Ogden | M | - | 3 years | |
| Seth Fischer | M | 68 | 29 years | |
| Sean Cao | M | - | 3 years | |
| Ronit Bendori | M | - | 6 years | |
| Frank Stonebanks | M | - | 6 years | |
| John A. Salvagno | M | - | 3 years | |
| Greg Harriman | M | - | 10 years | |
| Thomas Hoy | M | 62 | - | |
| Joseph Blechl | M | - | 2 years | |
| Angelo Scopelianos | M | 69 | 24 years | |
| Thomas Luby | M | - | 6 years | |
| Robert Sheroff | M | 69 | 12 years | |
| Patrick O'brien | M | 60 | - | |
| Elizabeth Anderson | F | 66 | 12 years | |
| Melissa McLaughlin | F | - | 12 years | |
| Desiree Ralls-Morrison | F | 57 | 8 years | |
| Valerie Love | F | 57 | 6 years | |
| Melanie Barstad | F | 71 | - | |
| Arnold G. Langbo | M | 86 | 19 years | |
| Ravi Kiron | M | 64 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 98 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elizabeth Hanna
- Personal Network
